Pemigatinib pemazyre a fgfr2 inhibitor blocks the abnormal fgfr2 protein in bile duct cancer cells and keeps them from growing and spreading to other places.
Does immunotherapy work for bile duct cancer.
October 29 2015 by nci staff.
National cancer institute steve rosenberg m d.
Study tests combination immunotherapy in advanced bile duct cancer.
Immunotherapy is a new cancer treatment approach that uses drugs vaccines and other therapies to activate the immune system s natural defenses so it can fight cancer.
It can be used to treat some advanced bile duct cancers that cannot be removed by surgery or have spread to distant areas after at least one previous chemotherapy treatment.
Cholangiocarcinoma also known as bile duct cancer is steadily rising in incidence worldwide.
Immunotherapy is the use of medicines to help a person s immune system better recognize and destroy cancer cells.
A patient with metastatic bile duct cancer treated with immunotherapy using her own mutation specific t cells has experienced regression of her metastatic lung and liver tumors that is ongoing for more than 2 years.
Symptoms often go undetected until the disease is far advanced.
Immunotherapy for bile duct cancer.
These drugs enter the bloodstream and reach all areas of the body making this treatment useful for some cancers that have spread to organs beyond the bile duct.
To learn more about how drugs that work on the immune system are used to treat cancer see cancer immunotherapy.
Learn more about cancer immunotherapy.
Many of these drugs are being tested in clinical trials to see if they might help treat bile duct cancer.